与每次取卵最大累积活产率相关的卵母细胞数取决于女性年龄:一项基于221221个治疗周期的群体研究
基于澳大利亚和新西兰辅助生殖数据库221221个自体卵母细胞取卵周期,分析不同年龄女性取卵数与每次取卵累积活产率的关系。校正年龄、产次和周期数后,取卵数是累积活产的显著预测因子(P<0.001);18-35岁女性取卵约25枚时累积活产率最高,36-44岁女性取卵超过30枚仍继续增加,45岁及以上女性约9枚。
要点
- 18-35岁女性取卵约25枚时累积活产率最高,30-34岁组达72%。
- 36-44岁女性取卵超过30枚时累积活产率仍继续增加,35-39岁组达68%。
- 45岁及以上女性累积活产率始终低于5%,该年龄组样本量较小。
核心结论
- 在辅助生殖技术中,观察到最大每次取卵累积活产率时的取卵数取决于女性年龄。
研究设计与样本
- 回顾性群体队列研究,使用澳大利亚和新西兰辅助生殖数据库2009年1月至2015年12月间的221221个自体卵母细胞取卵周期。
- 采用广义估计方程分析以处理同一女性多个周期的聚集性,并进行单因素和多因素回归分析。
- 纳入女性年龄与取卵数的交互项,以评估年龄对最佳取卵数的效应修饰作用。
主要发现
- 取卵数中位数为7枚(四分位距4-12),患者年龄中位数为36岁(四分位距33-40),总体累积活产率为32.2%。
- 校正女性年龄、产次和周期数后,取卵数仍是累积活产的显著预测因子(P<0.001)。
- 以取卵10-14枚为参照组,累积活产的校正比值比随取卵数变化:1-3枚为0.21(95%CI 0.20-0.22),4-9枚为0.56(95%CI 0.55-0.58),15-19枚为1.38(95%CI 1.34-1.43),20-24枚为1.75(95%CI 1.67-1.84),超过25枚为2.10(95%CI 1.96-2.25)。
- <30岁和30-34岁组取卵25枚后累积活产率分别达73%和72%,此后仅轻微增加;35-39岁和40-44岁组取卵30枚及以上时累积活产率分别达68%和40%,且随取卵数增加继续升高。
- 45岁及以上女性累积活产率始终低于5%,该年龄组样本量相对较小,结果稳健性可能不足。
关键数值与推荐
- 18-35岁女性取卵约25枚时累积活产率最高。
- 36-44岁女性取卵超过30枚时累积活产率仍继续增加。
- 45岁及以上女性取卵约9枚时累积活产率最高。
临床怎么用
- 研究结果提示临床医生和患者可了解年龄对取卵数与辅助生殖技术成功可能性的修饰效应。
局限性
- 作为大型回顾性数据库研究,存在无法校正的潜在混杂因素。
- 尽管研究基于两国辅助生殖周期的完整 ascertainment,但ANZARD未收集卵巢刺激方案、卵母细胞质量参数和若干重要患者特征。
- 45岁以上女性取卵超过15枚的周期数很少,导致这些估计值不可靠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the number of oocytes where the maximum cumulative live birth rate per aspiration (CLBR) is observed during ART in women of different ages? SUMMARY ANSWER: The maximum CLBR was observed when around 25 oocytes were retrieved in women between 18-35 years of age, around 9 oocytes in women more than 45 years of age and continued to increase beyond 30 oocytes in women between 36-44 years of age. WHAT IS KNOWN ALREADY: The live birth rate per fresh or frozen/thaw embryo transfer (FET) procedure has traditionally been the main measure of ART success. However, with the introduction of highly efficient embryo cryopreservation methods, CLBR encompassing live delivery outcomes from the fresh and all subsequent FET following a single ovarian stimulation and oocyte collection is increasingly viewed as a more meaningful measure of treatment success. There is evidence suggesting that larger oocyte yields are associated with increased likelihood of cumulative live birth per aspiration. Whether this association is the same across female ages has not yet been properly investigated. STUDY DESIGN, SIZE, DURATION: This is a large retrospective population-based cohort study using data from the Australian and New Zealand Assisted Reproduction Database (ANZARD). ANZARD contains information from all ART treatment cycles carried out in all fertility centres in Australia and New Zealand. Overall, 221 221 autologous oocyte aspiration cycles carried out between January 2009 to December 2015 were included in the analysis. PARTICIPANTS/MATERIALS, SETTING, METHODS: Cumulative live birth per aspiration was defined as at least one liveborn baby at ≥20 weeks gestation resulting from an ART aspiration cycle, including all fresh and FET resulting from the associated ovarian stimulation, until one live birth occurred or all embryos were used. Cycles where no oocytes were retrieved were excluded from analysis as there is no possibility of live birth. Analyses of data were performed using generalized estimating equations to account for the clustered nature of data (multiple cycles undertaken by a woman). Univariate and multivariable regression analysis was performed to identify and adjust for factors known to independently affect cumulative live birth per aspiration. An interaction term between female age and the number of oocytes retrieved was included to assess whether the age of the women was associated with a different optimal number of oocytes to achieve at least one live birth from an aspiration cycle (i.e. the effect-modifying role of female age). The likelihood of cumulative live birth per aspiration was calculated as odds ratios (ORs) with 95% CI. MAIN RESULTS AND THE ROLE OF CHANCE: The median number of oocytes retrieved was 7 (interquartile range, 4-12) and median age of patients was 36 (interquartile range, 33-40). The overall CLBR was 32.2%. The results from the multivariable regression analysis showedthat the number of oocytes retrieved remained a significant predictor (P < 0.001) of cumulative live birth per aspiration after adjusting for female age, parity and cycle count. Compared to the reference group of 10-14 oocytes retrieved, the adjusted odds for cumulative live birth per aspiration increased with the number of oocytes retrieved: 1-3 oocytes, 0.21 (95% CI, 0.20-0.22); 4-9 oocytes, 0.56 (95% CI, 0.55-0.58); 15-19 oocytes, 1.38 (95% CI, 1.34-1.43); 20-24 oocytes, 1.75 (95% CI, 1.67-1.84); and 2.10 (95% CI, 1.96-2.25) with more than 25 oocytes. After stratifying by female age group, the rate of increase in CLBR per additional oocyte retrieved was lower in the older age groups, indicating that higher oocyte yields were more beneficial in younger women. CLBR of patients in the <30 years and 30-34 years age groups appeared to reach a plateau (with only minimal increase in CLBR per additional oocyte retrieved) after retrieval of 25 oocytes at 73% and 72%, respectively, while CLBR of patients in the 35-39 years and 40-44 years age groups continued to increase with higher oocyte yields, reaching 68% and 40%, respectively, when 30 or more oocytes were retrieved. CLBR of patients aged 45 years and above remained consistently below 5%. Findings suggest that the number of oocytes retrieved where CLBR appears to be maximized is around 25 in women between 18-35 years, more than 30 in women between 36-44 years and around 9 in women 45 years and older. However, results for women aged 45 years and older may not be as robust due to the relatively small sample size available in this age group. LIMITATIONS, REASONS FOR CAUTION: As with all large retrospective database studies, there are potential confounders that cannot be accounted for. Despite the current study being based on complete ascertainment of ART cycles across two countries, ovarian stimulation protocols, oocyte quality parameters and a number of important patient characteristics are not collected by ANZARD. Additionally, a small number of cycles were available for women over 45 years yielding more than 15 oocytes, making these estimates unreliable. WIDER IMPLICATIONS OF THE FINDINGS: The results from this study demonstrate that the number of oocytes retrieved where the maximum CLBR is observed during ART is dependent on female age. This provides information for clinicians and patients to understand the modifying effect of age on the number of oocytes retrieved and the likelihood of success with ART. STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. The Fertility Society of Australia funds the National Perinatal Epidemiology and Statistics Unit to manage ANZARD and conduct national reporting of ART in Australia and New Zealand. Associate Professor Georgina Chambers (G.C.) is employed by the University of New South Wales (UNSW) and is director of the National Perinatal Epidemiology and Statistics Unit at UNSW. G.C. was also a paid member of the Australian governments Medicare Benefits Scheme taskforce on assisted reproductive technologies in 2017.
引用
- Law YJ, Zhang N, Venetis CA, et al. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles. Hum Reprod. 2019. PMID: 31398253. doi:10.1093/humrep/dez100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。